ArticleHeart Asia2010
A literature review of the cardiovascular risk-assessment tools: applicability among Asian population.
Article in Heart Asia, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Deep Learning Improves Prediction of Cardiovascular Disease-Related Mortality and Admission in Patients with Hypertension: Analysis of the Korean National Health Information Database.Journal of clinical medicine · 2022Article
- Cardiovascular risk assessment tools in Asia.Journal of clinical hypertension (Greenwich, Conn.) · 2022Article
- A Comparison of Statin Treatment Algorithms Based on the ACC/AHA and Philippine Guidelines for Primary Prevention of Dyslipidemia in Statin-Naive Filipino Patients.Journal of the ASEAN Federation of Endocrine Societies · 2022Review
- Article
- Sedentary lifestyle and Framingham risk scores: a population-based study in Riyadh city, Saudi Arabia.BMC cardiovascular disorders · 2019Article
- Expert opinion on the applicability of dyslipidemia guidelines in Asia and the Middle East.International journal of general medicine · 2018Article
- Statin-centric versus low-density lipoprotein-centric approach for atherosclerotic cardiovascular disease prevention: a Singapore perspective.Singapore medical journal · 2016Review
- Applicability of the Existing CVD Risk Assessment Tools to Type II Diabetics in Oman: A Review.Oman medical journal · 2015Review
- Chapter 5: Referral to specialists and models of care.Kidney international supplements · 2013Article
- Chapter 4: Other complications of CKD: CVD, medication dosage, patient safety, infections, hospitalizations, and caveats for investigating complications of CKD.Kidney international supplements · 2013Article
- Cardiovascular disease risk factor patterns and their implications for intervention strategies in Vietnam.International journal of hypertension · 2012Article
- "Healthy Heart, Healthy You": Ten-Year Cardiovascular Disease (CVD) Risk among Adults in Anekal Taluk Hospital, Bangalore Urban District, Karnataka.Indian journal of community medicine : official publication of Indian Association of Preventive & Social MedicineArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCardiovascular diseases, the main causes of hospitalisations and death globally, have put an enormous economic burden on the healthcare system. Several risk factors are associated with the occurrence of cardiovascular events. At the heart of efficient prevention of cardiovascular disease is the concept of risk assessment. This paper aims to review the available cardiovascular risk-assessment tools and its applicability in predicting cardiovascular risk among Asian populations.
methodsA systematic search was performed using keywords as MeSH and Boolean terms.
resultsA total of 25 risk-assessment tools were identified. Of these, only two risk-assessment tools (8%) were derived from an Asian population. These risk-assessment tools differ in various ways, including characteristics of the derivation sample, type of study, time frame of follow-up, end points, statistical analysis and risk factors included.
conclusionsVery few cardiovascular risk-assessment tools were developed in Asian populations. In order to accurately predict the cardiovascular risk of our population, there is a need to develop a risk-assessment tool based on local epidemiological data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.